Sahlgrenska Science Park celebrates VERIGRAFT’s regulatory milestone and extended support from Vinnova
CO-AX, the healthtech accelerator at Sahlgrenska Science Park, proudly acknowledges the recent achievements of VERIGRAFT, a prominent member of its life science community. VERIGRAFT has reached a major regulatory safety milestone in the TECVI-1 trial, further supported by extended funding from Vinnova CAMP for their arterial graft development project.
TECVI-1 trial: a major step forward
The
